MBX Biosciences, Inc. Common Stock (MBX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $2.78B
Last updated: Nov 17, 2026 at 11:06 AM ET
MBX Biosciences, Inc. Common Stock (MBX) Earnings: Report Dates and Results
MBX Biosciences, Inc. Common Stock (MBX) is expected to report earnings on Mar 10, 2027. In the quarter ended Sep 30, 2026, MBX Biosciences, Inc. Common Stock reported EPS of -$1.29, below the -$0.80 estimate. It beat the EPS estimate in 6 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
MBX has an expected report date of Mar 10, 2027.
Earnings History
Of the 9 quarters below that had an estimate, MBX beat 6 and missed 3. The widest gap in the table came in the quarter ended Sep 30, 2026, when EPS landed 61.25% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported |
|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$1.29 | -$0.80 | -$0.96 - -$0.74 | -61.25% | Miss | N/A | 7 | 0 up, 4 down | Nov 9, 2026 |
| Jun 30, 2026 | -$0.78 | -$0.68 | -$0.78 - -$0.46 | -14.71% | Miss | N/A | 7 | 6 up, 0 down | Aug 6, 2026 |
| Mar 31, 2026 | -$0.51 | -$0.58 | -$0.66 - -$0.54 | +12.07% | Beat | N/A | 7 | 0 up, 1 down | May 7, 2026 |
| Dec 31, 2025 | -$0.49 | -$0.60 | -$0.76 - -$0.46 | +17.88% | Beat | N/A | 7 | 1 up, 0 down | Mar 12, 2026 |
| Sep 30, 2025 | -$0.63 | -$0.68 | -$0.78 - -$0.51 | +7.35% | Beat | N/A | 5 | 2 up, 1 down | Nov 6, 2025 |
| Jun 30, 2025 | -$0.58 | -$0.77 | N/A | +24.68% | Beat | N/A | N/A | N/A | Aug 7, 2025 |
| Mar 31, 2025 | -$0.71 | -$0.77 | N/A | +7.79% | Beat | N/A | N/A | N/A | May 12, 2025 |
| Dec 31, 2024 | -$0.47 | -$0.59 | N/A | +19.85% | Beat | N/A | N/A | N/A | Mar 17, 2025 |
| Sep 30, 2024 | -$2.78 | -$2.72 | N/A | -2.21% | Miss | N/A | N/A | N/A | Nov 7, 2024 |
| Jun 30, 2024 | -$11.47 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 23, 2024 |
Annual EPS
| Fiscal year ended | EPS | Change |
|---|---|---|
| Sep 30, 2026 | -$2.58 | N/A |
| Jun 30, 2026 | -$1.29 | N/A |
| Dec 31, 2025 | -$2.41 | N/A |
| Dec 31, 2024 | -$14.72 | N/A |
Frequently Asked Questions About MBX
When is MBX Biosciences, Inc. Common Stock's next earnings date?
MBX Biosciences, Inc. Common Stock's next earnings report is expected for Mar 10, 2027.
Did MBX beat earnings estimates last quarter?
No. MBX Biosciences, Inc. Common Stock reported EPS of -$1.29 for the quarter ended Sep 30, 2026, below the -$0.80 estimate by 61.25%.
What EPS do analysts expect from MBX next quarter?
The consensus EPS estimate for MBX Biosciences, Inc. Common Stock for the quarter ending Dec 31, 2026 is -$0.99 from 12 analysts, with estimates from -$1.35 to -$0.84.
How often does MBX beat earnings estimates?
MBX Biosciences, Inc. Common Stock beat the EPS estimate in 6 of the last 8 quarters, with an average surprise of +1.71%.
MBX pages: Overview, Earnings, Forecast, Financials, Competitors